FI852527L - Alifatiska tioetrar. - Google Patents

Alifatiska tioetrar.

Info

Publication number
FI852527L
FI852527L FI852527A FI852527A FI852527L FI 852527 L FI852527 L FI 852527L FI 852527 A FI852527 A FI 852527A FI 852527 A FI852527 A FI 852527A FI 852527 L FI852527 L FI 852527L
Authority
FI
Finland
Prior art keywords
tioetrar
aliphatic
aliphatic tioetrar
Prior art date
Application number
FI852527A
Other languages
English (en)
Finnish (fi)
Other versions
FI852527A0 (fi
Inventor
Sprecher Andreas Von
Ivan Ernest
Alan Joseph Main
Andreas Beck
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI852527A0 publication Critical patent/FI852527A0/fi
Publication of FI852527L publication Critical patent/FI852527L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI852527A 1984-06-28 1985-06-26 Alifatiska tioetrar. FI852527L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH311584 1984-06-28
CH61785 1985-02-12

Publications (2)

Publication Number Publication Date
FI852527A0 FI852527A0 (fi) 1985-06-26
FI852527L true FI852527L (fi) 1985-12-29

Family

ID=25685130

Family Applications (1)

Application Number Title Priority Date Filing Date
FI852527A FI852527L (fi) 1984-06-28 1985-06-26 Alifatiska tioetrar.

Country Status (13)

Country Link
US (1) US4649215A (no)
EP (1) EP0170048B1 (no)
AU (1) AU4422985A (no)
CA (1) CA1276393C (no)
DE (1) DE3582527D1 (no)
DK (1) DK291485A (no)
ES (1) ES8606260A1 (no)
FI (1) FI852527L (no)
GR (1) GR851563B (no)
IL (1) IL75620A (no)
NO (1) NO161177C (no)
NZ (1) NZ212573A (no)
PT (1) PT80716B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6257A (ja) * 1985-03-19 1987-01-06 Green Cross Corp:The 含硫アミン−脂肪酸のアミド誘導体
FI864901A (fi) * 1985-12-06 1987-06-07 Ciba Geigy Ag Hydroxitioetrar.
US4785004A (en) * 1985-12-23 1988-11-15 Ciba-Geigy Corporation Aromatic thioethers
KR870011086A (ko) * 1986-05-29 1987-12-19 벤자민 에프. 램버트 포스포리파제 a₂억제제 및 그의 합성방법
US5149717A (en) * 1988-03-29 1992-09-22 Ciba-Geigy Corporation Alkanophenones useful for treating allergies
EP0419410A3 (en) * 1989-09-19 1991-08-14 Ciba-Geigy Ag Alkanophenones
DE4228455A1 (de) * 1992-08-26 1994-09-15 Beiersdorf Ag Kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an Thiolen und/oder Thiolderivaten
US5464754A (en) * 1993-08-17 1995-11-07 The Regents Of The University Of California Assay and substrate for arachidonoyl-specific phospholipase A2
CA2426203A1 (en) 2000-10-23 2002-05-02 The Arizona Disease Control Research Commission Anticancer agents based on regulation of protein prenylation
GB201604316D0 (en) 2016-03-14 2016-04-27 Avexxin As Combination therapy
AU2017329957B2 (en) * 2016-09-21 2020-05-07 Avexxin As Pharmaceutical composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3262587D1 (en) * 1981-03-03 1985-04-25 Lilly Industries Ltd Leukotriene analogues, their preparation and use in pharmaceutical compositions
US4513005A (en) * 1981-06-18 1985-04-23 Lilly Industries Limited SRS-A antagonists
DK130984A (da) * 1983-03-07 1984-09-08 Smithkline Beckman Corp Leukotrien-antagonister
EP0123543B1 (en) * 1983-04-21 1988-02-03 Merck Frosst Canada Inc. Leukotriene antagonists, their production and use and compositions containing them

Also Published As

Publication number Publication date
NZ212573A (en) 1989-03-29
NO161177C (no) 1989-07-12
CA1276393C (en) 1990-11-13
ES544534A0 (es) 1986-04-16
EP0170048B1 (de) 1991-04-17
EP0170048A3 (en) 1988-08-10
NO852589L (no) 1985-12-30
DK291485A (da) 1985-12-29
IL75620A (en) 1989-05-15
DK291485D0 (da) 1985-06-27
NO161177B (no) 1989-04-03
GR851563B (no) 1985-11-25
US4649215A (en) 1987-03-10
AU4422985A (en) 1986-01-02
EP0170048A2 (de) 1986-02-05
IL75620A0 (en) 1985-10-31
DE3582527D1 (en) 1991-05-23
FI852527A0 (fi) 1985-06-26
ES8606260A1 (es) 1986-04-16
PT80716B (de) 1987-03-31
PT80716A (de) 1985-07-01

Similar Documents

Publication Publication Date Title
DE3583455D1 (de) Salbenbase.
DE3581430D1 (de) Detergens.
DE3576268D1 (de) Hoergeraet.
DE3585265D1 (de) Fibronektinpraeparate.
DE3581707D1 (de) Neigungsmesser.
DE3583080D1 (de) Mikrorechner.
FI77959B (fi) Hushaolls- eller motsvarande koeksanordning.
FI851602L (fi) Fenolderivat.
FI840024A (fi) Instaellbart saengbotten.
DE3582060D1 (de) Homopropargylamine.
DE3578421D1 (de) Glycidyloxydiketone.
FI852527A0 (fi) Alifatiska tioetrar.
FI73926B (fi) Standardhastighetsregulator foer motorfordon.
DE3577708D1 (de) Diphenylhexafluorpropanabkoemmlinge.
DE3584628D1 (de) Xenocoumacine.
FI851407A0 (fi) Pappershjaelpmedel.
DE3586085D1 (de) Antitumor-4-hydroxy-2-zyklopentenonen.
FI80907B (fi) Kraftunderstoedd hudappliseringsapparat.
DE3579862D1 (de) Mikrorechner.
DE3574867D1 (de) Aminokarnitine.
DE3587711D1 (de) Minaktivin.
FI83368B (fi) Handelvapen.
DE3574494D1 (de) Selbstzerlegerzuender.
FI842507A0 (fi) Varvraeknare.
DE3576291D1 (de) Entaester.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: CIBA-GEIGY AG